Wed, Mar 4, 2015, 8:12 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

IntelliCell BioSciences, Inc. Message Board

  • lovetofishhh lovetofishhh Apr 24, 2014 3:40 PM Flag

    Need more updates on the NEWS!

    Dr. James Andrews, Respected Orthopedic Surgeon and Founding Member of American Sports Medicine Institute, To Serve as Principal Investigator

    BURLINGTON, Mass., April 15, 2014 /PRNewswire/ -- inVentiv Health Clinical, a leading global supplier of drug development services, announced today that it has been selected for an osteoarthritis Investigational New Drug Application (IND) by the innovative regenerative medicine biotechnology company IntelliCell BioSciences, Inc., (OTCQB:SVFC). IntelliCell will be studying the use of adult autologous vascular cells from blood vessels in adipose tissue to treat osteoarthritis of the knee.

    The principal investigator is Dr. James Andrews, an orthopedic surgeon known internationally for his scientific and clinical research into knee, shoulder and elbow injuries. Dr. Andrews is a founding member of the American Sports Medicine Institute, author of numerous scientific articles and books and founding partner and medical director at the Andrews Institute in Gulf Breeze, Florida.

    inVentiv Clinical will work with Dr. Andrews to develop investigational clinical study protocols and will serve as the Clinical Research Organization (CRO) on trials conducted at the Pensacola Center of the Andrews Institute.

    IntelliCell's technology for isolating stromal vascular fraction cells from the vasculature of adipose tissue has been used to treat more than 60 knees. IntelliCell's Chief Executive Officer, Dr. Steven Victor, said this is what we believe will be the first of several clinical trials for the biotech company studying the use of its technology in treating a variety of diseases and conditions.

    "inVentiv Clinical has extensive therapeutic experience in general pain and osteoarthritis programs and a focus on partnering with innovative bioscience companies," said Raymond Hill, President of inVentiv Health Clinical. "We are looking forward to our work with Dr. Andrews and contributing to advances in the treatment of osteoarthriti

    Sentiment: Buy

 
SVFC
0.00010.0000(0.00%)Mar 4 2:39 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Vivint Solar, Inc.
NYSEWed, Mar 4, 2015 4:01 PM EST
Wayfair Inc.
NYSEWed, Mar 4, 2015 4:02 PM EST